FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Lindstrom Richard 		2. Issuer Name and Ticker or Trading Symbol

OccuLogix, Inc. [ OCCX ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

2811 WESTWOOD ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/6/2008
(Street)

WAYZATA, MN 55391
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common shares   10/6/2008     P    85938   (1) A $2.5   (1) 86238   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options   $2.25   (2) 10/6/2008     A     14448   (2)        (3) 6/7/2015   Common shares   14448   (2) $2.25   (2) 18848   (4) D    

Explanation of Responses:
( 1)  OccuLogix, Inc. (?OCCX?) effected a 1:25 reverse stock split on Oct. 7, 2008. The number of common shares and the acquisition price reported on this Form 4 reflect the reverse stock split. On Oct. 6, 2008, Dr. Lindstrom had acquired 2,148,438 common shares at $0.10 per share, which shares have been reverse split into 85,938 common shares.
( 2)  The exercise price of the options and the number of underlying shares reported on this Form 4 have been reverse split-adjusted. The options are the result of the assumption by OCCX of options of OcuSense, Inc. on October 6, 2008. Upon such assumption, Dr. Lindstrom held options exercisable into 361,183 OCCX common shares with a per share exercise price of $0.09, which options have been reverse split into options exercisable into 14,448 OCCX common shares with a per share exercise price of $2.25.
( 3)  The options are fully vested.
( 4)  The number of OCCX options held by Dr. Lindstrom following the transaction reported on this Form 4 has been reverse split-adjusted.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Lindstrom Richard
2811 WESTWOOD ROAD
WAYZATA, MN 55391 		X



Signatures
/s/ Richard Lindstrom 10/8/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Occulogix (MM) (NASDAQ:OCCXD)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Occulogix (MM) Charts.
Occulogix (MM) (NASDAQ:OCCXD)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Occulogix (MM) Charts.